MAP Pharmaceuticals, Inc. (MAPP) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $27.93 -1.31%
Financial Fact:
Income (loss) from operations: -12.62M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Income (loss) from operations: -12.62M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q2 loss of ($0.28), $0.10 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $2.55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
- VNET Group (VNET) Misses Q2 EPS by 164c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
